291 related articles for article (PubMed ID: 33536075)
1. Unstimulated whole salivary flow in Sjögren's Syndrome: systematic literature review and meta-analysis.
Martínez-Ceballos MA; Aguilera N; Garzón-González KC; Cajamarca-Baron J; Alzate-Granados JP; Rojas-Villarraga A
Adv Rheumatol; 2021 Feb; 61(1):8. PubMed ID: 33536075
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of unstimulated flow rates of whole and palatal saliva in healthy patients wearing complete dentures and in patients with Sjogren's syndrome.
Márton K; Boros I; Fejérdy P; Madléna M
J Prosthet Dent; 2004 Jun; 91(6):577-81. PubMed ID: 15211301
[TBL] [Abstract][Full Text] [Related]
3. Elucidating the role of hyposalivation and autoimmunity in oral candidiasis.
Billings M; Dye BA; Iafolla T; Grisius M; Alevizos I
Oral Dis; 2017 Apr; 23(3):387-394. PubMed ID: 27998016
[TBL] [Abstract][Full Text] [Related]
4. Measurement of whole unstimulated salivary flow in the diagnosis of Sjögren's syndrome.
Speight PM; Kaul A; Melsom RD
Ann Rheum Dis; 1992 Apr; 51(4):499-502. PubMed ID: 1586248
[TBL] [Abstract][Full Text] [Related]
5. Whole stimulated salivary flow: correlation with the pathology of inflammation and damage in minor salivary gland biopsy specimens from patients with primary Sjögren's syndrome but not patients with sicca.
Bookman AA; Shen H; Cook RJ; Bailey D; McComb RJ; Rutka JA; Slomovic AR; Caffery B
Arthritis Rheum; 2011 Jul; 63(7):2014-20. PubMed ID: 21337320
[TBL] [Abstract][Full Text] [Related]
6. Sialendoscopy enhances salivary gland function in Sjögren's syndrome: a 6-month follow-up, randomised and controlled, single blind study.
Karagozoglu KH; Vissink A; Forouzanfar T; Brand HS; Maarse F; Jager DHJ
Ann Rheum Dis; 2018 Jul; 77(7):1025-1031. PubMed ID: 29475854
[TBL] [Abstract][Full Text] [Related]
7. Sialendoscopy increases saliva secretion and reduces xerostomia up to 60 weeks in Sjögren's syndrome patients: a randomized controlled study.
Karagozoglu KH; Vissink A; Forouzanfar T; de Visscher JGAM; Maarse F; Brand HS; van de Ven PM; Jager DHJ
Rheumatology (Oxford); 2021 Mar; 60(3):1353-1363. PubMed ID: 32949144
[TBL] [Abstract][Full Text] [Related]
8. Oral health-related quality of life in primary Sjögren's syndrome.
Fernández-Martínez G; Zamora-Legoff V; Hernández Molina G
Reumatol Clin (Engl Ed); 2020; 16(2 Pt 1):92-96. PubMed ID: 29754950
[TBL] [Abstract][Full Text] [Related]
9. World Workshop on Oral Medicine VII: Immunobiologics for salivary gland disease in Sjögren's syndrome: A systematic review.
Gueiros LA; France K; Posey R; Mays JW; Carey B; Sollecito TP; Setterfield J; Woo SB; Culton D; Payne AS; Lodi G; Greenberg MS; De Rossi S
Oral Dis; 2019 Jun; 25 Suppl 1(Suppl 1):102-110. PubMed ID: 31140693
[TBL] [Abstract][Full Text] [Related]
10. Cytokine concentrations in stimulated whole saliva among patients with primary Sjögren's syndrome, secondary Sjögren's syndrome, and patients with primary Sjögren's syndrome receiving varying doses of interferon for symptomatic treatment of the condition: a preliminary study.
Streckfus C; Bigler L; Navazesh M; Al-Hashimi I
Clin Oral Investig; 2001 Jun; 5(2):133-5. PubMed ID: 11480812
[TBL] [Abstract][Full Text] [Related]
11. Significance and Implications of Patient-reported Xerostomia in Sjögren's Syndrome: Findings From the National Institutes of Health Cohort.
Billings M; Dye BA; Iafolla T; Baer AN; Grisius M; Alevizos I
EBioMedicine; 2016 Oct; 12():270-279. PubMed ID: 27639822
[TBL] [Abstract][Full Text] [Related]
12. A comparison of salivary gland hypofunction in primary and secondary Sjögren's syndrome.
Dawson LJ; Holt DJ; Higham SM; Longman LP; Field EA
Oral Dis; 2001 Jan; 7(1):28-30. PubMed ID: 11354918
[TBL] [Abstract][Full Text] [Related]
13. Salivary gland dysfunction and xerostomia in Sjögren's syndrome.
Jensen SB; Vissink A
Oral Maxillofac Surg Clin North Am; 2014 Feb; 26(1):35-53. PubMed ID: 24287192
[TBL] [Abstract][Full Text] [Related]
14. Oral pilocarpine HCl stimulates labial (minor) salivary gland flow in patients with Sjögren's syndrome.
Rhodus NL
Oral Dis; 1997 Jun; 3(2):93-8. PubMed ID: 9467349
[TBL] [Abstract][Full Text] [Related]
15. Salivary chemokine levels in patients with primary Sjogren's syndrome.
Lee YJ; Scofield RH; Hyon JY; Yun PY; Lee HJ; Lee EY; Lee EB; Song YW
Rheumatology (Oxford); 2010 Sep; 49(9):1747-52. PubMed ID: 20525739
[TBL] [Abstract][Full Text] [Related]
16. Primary Sjögren's syndrome: salivary gland function and clinical oral findings.
Pedersen AM; Reibel J; Nordgarden H; Bergem HO; Jensen JL; Nauntofte B
Oral Dis; 1999 Apr; 5(2):128-38. PubMed ID: 10522209
[TBL] [Abstract][Full Text] [Related]
17. [Xerostomia, hyposialia, sicca syndrome--quantitative disturbances of the salivary flow rate].
Slezák R; Berglová I; Krejsek J
Vnitr Lek; 2011 Apr; 57(4):339-46. PubMed ID: 21612055
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic utility of major salivary gland ultrasonography in primary Sjögren's syndrome.
Hammenfors DS; Brun JG; Jonsson R; Jonsson MV
Clin Exp Rheumatol; 2015; 33(1):56-62. PubMed ID: 25535773
[TBL] [Abstract][Full Text] [Related]
19. The frequency of sicca symptoms and Sjögren's syndrome in patients with systemic sclerosis.
Kobak S; Oksel F; Aksu K; Kabasakal Y
Int J Rheum Dis; 2013 Feb; 16(1):88-92. PubMed ID: 23441777
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of palatal saliva flow rate and oral manifestations in patients with Sjögren's syndrome.
Márton K; Boros I; Varga G; Zelles T; Fejérdy P; Zeher M; Nagy G
Oral Dis; 2006 Sep; 12(5):480-6. PubMed ID: 16910919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
